| Heading: |
Neurodiversity: Medical Treatments |
| Question ID: |
1798450 |
| UIN: |
49098 |
| House: |
Commons |
| Date tabled: |
2025-04-29 |
| Asking Member ID: |
5055 |
| Asking Member display name: |
Max Wilkinson
|
| Asking Member handle: |
mpmwilko
|
| Asking Member Twitter reference: |
@mpmwilko
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of levels of access to medication by neurodivergent people who have been diagnosed (a) by the NHS and (b) privately. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-05-08 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4359 |
| Answering Member display name: |
Stephen Kinnock
|
| Answering Member handle: |
skinnock
|
| Answering Member Twitter reference: |
@skinnock
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Autism is a neurodevelopmental condition, related to how the brain develops, rather than an illness. Although some approaches are particularly helpful for autistic people, and medication may be prescribed for co-existing issues, autism is not treated dire... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |